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Mutations in regulatory regions including enhancers are an important
source of variation and innovation during evolution. Enhancers can evolve
by changes in the sequence, arrangement and repertoire of transcription
factor binding sites, but whole enhancers can also be lost or gained in certain
lineages in a process of turnover. The proopiomelanocortin gene (Pomc),
which encodes a prohormone, is expressed in the pituitary and hypo-
thalamus of all jawed vertebrates. We have previously described that
hypothalamic Pomc expression in mammals is controlled by two enhan-
cers—nPE1 and nPE2—that are derived from transposable elements and
that presumably replaced the ancestral neuronal Pomc regulatory regions.
Here, we show that nPE1 and nPE2, even though they are mammalian
novelties with no homologous counterpart in other vertebrates, nevertheless
can drive gene expression specifically to POMC neurons in the hypothala-
mus of larval and adult transgenic zebrafish. This indicates that when
neuronal Pomc enhancers originated de novo during early mammalian evol-
ution, the newly created cis- and trans-codes were similar to the ancestral
ones. We also identify the neuronal regulatory region of zebrafish pomca
and confirm that it is not homologous to the mammalian enhancers. Our
work sheds light on the process of gene regulatory evolution by showing
how a locus can undergo enhancer turnover and nevertheless maintain the
ancestral transcriptional output.1. Introduction
The understanding of organismal evolution at the molecular level is closely
related to the study of gene regulation, as mutations in regulatory regions in
the DNA are considered one of the main drivers of biological evolution [1].
Transcriptional enhancers are cis-acting DNA elements that work as arrays of
transcription factor binding sites (TFBSs) and control the transcriptional activity
of genes located nearby. The identification and study of enhancers is a difficult
task, as there are no general, fixed rules regarding the location or sequence com-
position of such elements. Compared with coding regions, which are generally
highly constrained by protein structure and function, enhancers are freer to
evolve, because TFBSs are small (6–10 nucleotides long) and accept much
higher levels of sequence divergence than the genetic code, i.e. each transcrip-
tion factor can recognize a variety of binding site sequences. In addition,
although some examples of rigid enhancer organization exist [2,3], the order
of TFBSs on a given enhancer can be quite flexible [4]. Finally, enhancers act
at a distance and can even be embedded within neighbouring loci [5–9], indi-
cating a large degree of positional freedom of enhancers in relation to the genes
they control. Thus, while new protein coding genes mostly appear by
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Figure 1. Scheme of possible evolutionary paths of enhancers. Top: ancestral enhancer (box) has a given arrangement of transcription factor binding sites (TFBSs,
coloured squares) in a background of near-neutral sequence (yellow). (a) As evolutionary time goes by, the enhancer can accumulate relatively few mutations
(indicated as white areas in box) and give rise to homologous enhancers that can be aligned (i.e. are ‘conserved’) between species. (b) If TFBSs undergo
much turnover and the accumulation of mutations is too high, homologous enhancers may no longer be alignable (i.e. be ‘non-conserved’). (c) The ancestral
enhancer becomes inactive by the accumulation of mutations, but this is compensated by the appearance of a new enhancer elsewhere in the locus that fulfils
the same regulatory function. In the path to (c), both functional enhancers coexist for some time until one of them becomes non-functional.
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an enhancer can change quickly over evolutionary time
and new enhancers can appear in new locations and replace
ancient ones.(a) Enhancer evolution in vertebrates
Traditionally, enhancers were found by the patient testing of
different DNA regions coming from the locus under study in
reporter gene assays in cell culture and in transgenic mice.
With the advent of whole-genome sequencing, it was quickly
recognized that enhancers and other regulatory regions might
be identified by the sequence alignments of genomes of differ-
ent organisms, the rationale being that non-coding, functional
DNA regions would show signs of purifying selection (i.e.
constraint) and have a higher level of sequence conservation
than non-functional, neutrally evolving regions [11,12].
Thus, early alignments of human and mouse genomes
allowed for the identification of candidate regulatory regions
and, as more genomes were sequenced, comparisons of mam-
malian genomes with those of teleost fishes such as fugu
(Takifugu rubripes) and zebrafish (Danio rerio) allowed for the
identification of thousands of conserved non-coding elements
(CNEs) that have maintained their function throughout ver-
tebrate evolution [13–15]. In fact, many of these highly
conserved CNEs behave as enhancers when tested in trans-
genic mice and/or zebrafish [5,14–16], indicating that
enhancer function can be conserved during the 450 million
years that have passed since the divergence of the teleost
and tetrapod lineages [17].
But, can all enhancers in a given genome be simply ident-
ified by phylogenetic footprinting? Because enhancers can
evolve relatively fast, the answer to this question is not
easy, as many circumstances can be envisaged that would
lead to failure in the identification of enhancers by sequence
conservation between two given lineages (figure 1). Thus,
(i) orthologous enhancers (i.e. originated from a common
ancestral sequence) can mutate redundant nucleotideswithin TFBSs and/or reshuffle their TFBSs during evolution
(TFBS turnover), but may still be alignable, something that
facilitates their identification, as in the case of CNEs. How-
ever, (ii) it is also possible that extensive mutations can
occur that maintain enhancer function but erase alignability,
preventing a straightforward identification by sequence con-
servation. Alternatively, (iii) current enhancers performing
the same regulatory function in two different lineages may
be non-homologous (analogous), being rather the result of
the de novo appearance of a new enhancer in a different
location of the locus in one or both of the lineages, and the
ancestral enhancer may be lost in at least one of them (enhan-
cer turnover). Of course, it is also possible that enhancers are
gained or lost independently of the fate of the ancestral
enhancers, again leading to lineage-specific differences in
enhancer repertoire. As for the regulatory consequences of
TFBS and enhancer turnover, three non-mutually exclusive
alternatives exist: (i) either reshuffling and turnover may
happen without altering the ancestral transcriptional activity
of the controlled gene, i.e. ‘things change to stay the same’;
(ii) enhancer turnover occurs modifying quantitative or quali-
tative traits of the spatio-temporal gene expression domain
that may produce phenotypic changes, i.e. longer limbs,
darker colour, etc.; or (iii) enhancer turnover originates com-
pletely novel patterns of expression in different lineages,
leading to regulatory innovation with reflections in the mor-
phology and physiology of organisms.
Hence, given enough time, it is expected that TFBS and
enhancer reshuffling and turnover will erase sequence
similarity in different lineages, and the power to detect func-
tional sequence by comparative approaches will depend on
the distance of the species analysed, meaning that as the phy-
logenetic distance increases, the proportion of CNEs should
decrease. For instance, Prabhakar et al. [18] identified 170 000
CNEs in a human–rodent comparison, but this number
dropped to 40 000 in human–chicken and 5700 in human–
fugu comparisons. When tested in transgenic mouse embryos,
27% of human–rodent CNEs (mammalian-specific) were
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lar to that obtained with human–fugu CNE (29% [16]).
Mammalian-specific and vertebrate-specific enhancers seem
to be distributed non-homogeneously among genes, as enhan-
cers conserved between mammals and fish are more common
near genes involved in embryonic development, suggesting
that genes with complex spatio-temporal expression patterns
are less flexible in their enhancer organization and architecture
compared with genes with other functions [19,20]. In con-
clusion, the proportion of enhancers in the human genome
that will be identifiable by phylogenetic footprinting is still
unclear. The recent sequencing of 29 mammalian genomes
should be an invaluable tool to help identify enhancers
common to mammals or, at least, most mammalian groups
[21]. In the case of enhancers withmore restricted distribution,
such as primate- or even human-specific enhancers, their
identification might only be possible by conventional func-
tional assays or aided by epigenetic marks typical for
enhancers in the locus under study [22,23]. Concerning
the latter strategy, many investigations in recent years have
used genome-wide chromatin immunoprecipitation to map
epigenetic marks that are typical for enhancers and, in some
cases, to test the elements in transgenic mouse analysis
(reviewed in [24,25]). Such studies have detected a large pro-
portion of enhancers that are conserved among several
mammals but also a significant fraction of enhancers without
apparent evolutionary constraint [22,26,27]. It remains to be
tested, however, the relative importance of conserved versus
weakly- or non-conserved enhancers in the regulation of
the genes they control. Although there are well-characterized
examples of cis-acting regulatory regions restricted to
particular mammalian lineages (e.g. [28,29]), several disease-
associated mutations mapping to non-coding regions in
humans have turned out to reside within phylogenetically
conserved enhancers [6,30–36].(b) Zebrafish as a tool to investigate enhancer evolution
When it comes to studying human enhancers, researchers
have traditionally studied reporter gene expression in trans-
genic mice as a gold standard. Being mammals, mice are
suitable models to test the activity of human enhancers,
with the invaluable advantage over cell culture systems that
enhancer activity can be analysed in a spatio-temporal way
and simultaneously in all tissues and cell types. There are,
however, other attractive vertebrate models that can be
used to study enhancers by transgenesis, including the teleost
zebrafish, which allows for quicker and cheaper transgenic
assays [37]. Mammals and zebrafish share thousands of
CNEs that can work as enhancers, and zebrafish transgenesis
plays an important role in the analysis of such conserved
genetic elements [14,15,38–41].
As discussed earlier, the few thousand enhancers that are
conserved between mammals and teleosts should constitute
only a fraction of the total [18], as TFBS and enhancer turn-
over tend to erase sequence similarity during evolution.
Recent high-throughput studies participating in the mouse
ENCODE project detected 230 000 elements with enhancer-
type signatures based on the genomic distribution of certain
epigenetic marks in murine cells [42]. Can zebrafish transgen-
esis be used to study mammalian enhancers that are not
conserved in teleosts? The answer to this question is yes, as
it has been found in some experiments that mammalianenhancers without obvious teleost orthologues can neverthe-
less drive specific transgene expression in zebrafish embryos
[39,43,44], indicating that at least part of the underlying cis-
(TFBS composition or order) aswell as trans- (transcription fac-
tors) elements are conserved inmammals and teleosts inmany
diverged enhancers. It is likely that many of these non-con-
served enhancers do possess orthologues that cannot be
readily identified owing to the turnover of neutral and redun-
dant nucleotide sites within the enhancers in each lineage
(TFBS turnover). Indeed, using the genome of the frogXenopus
tropicalis, an evolutionary intermediate reference between
mammals and teleosts, 1500 CNEs derived from human and
zebrafish genomes have been found that do not align to each
other but do align with elements in the frog [45]. When ana-
lysed in detail, such elements show evidence of TFBS
conservation that cannot be detected in whole-genome align-
ments and, when tested in transgenic zebrafish, many
elements display enhancer activity, indicating that the lack of
mammal–fish identity of these orthologous enhancers was
caused by the accumulation of mutations within the ancestral
sequences during the evolution of each lineage [45]. Apart
from turnover of TFBS sequence within enhancers, evolution
can also lead to the appearance of non-orthologous novel
enhancers and, eventually, to enhancer turnover with com-
plete functional loss of the ancestral sequence (figure 1). In
practice, however, it is difficult to be certain whether the
lack of overt sequence identity of such non-conserved
mammal–fish enhancers is the result of TFBS sequence turn-
over in orthologous enhancers or due to an enhancer
appearing de novo, unless a detailed knowledge of the evol-
utionary history of the enhancer in at least one of the two
lineages is found [46,47]. Here, we show that two mouse
enhancers of the proopiomelanocortin gene (Pomc) that cer-
tainly appeared in the mammalian lineage direct appropriate
reporter gene expression to homologous neurons in the
ventromedial hypothalamus of transgenic zebrafish.(c) Evolution of Pomc transcriptional expression
The Pomc gene encodes a prohormone found in all vertebrates
that is processed to several bioactive peptides to orchestrate
the stress response. Pomc is expressed in the pituitary gland
and brain, mainly in the hypothalamus, and its derived pep-
tides are involved in processes as diverse as glucocorticoid
release, stress-induced analgesia, energy balance control
and, in fishes and amphibians, background colour adaptation
[48–50]. Mammals, birds and other tetrapods have only one
Pomc copy, but zebrafish and other teleosts, including fugu
and Tetraodon nigroviridis, have two Pomc paralogues—pomca
and pomcb—that date from the ancient whole-genome
duplication in the teleost lineage around 320 Ma [51]. In zebra-
fish, pomca is expressed in the anterior and intermediate lobes
of the pituitary aswell as in the ventral hypothalamus, just like
the tetrapod gene [52,53]. The expression pattern of zebrafish
pomcb is unknown, but the Tetraodon homologue is expressed
in the preoptic area of the brain and pituitary [51].
Pituitary and hypothalamic Pomc expression are con-
trolled by different regulatory regions. In the mammalian
pituitary, there is a large body of evidence that Pomc
expression is regulated by several TFBSs present in the prox-
imal promoter [54–56], as well as by a mammalian-conserved
distal enhancer [57]. In the zebrafish, similar to mammals, it
has been found that a construct carrying the proximal
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fluorescent protein (GFP) expression to the anterior and
intermediate lobes of the pituitary, but not to ventral hypo-
thalamic neurons [52]. A similar construct carrying 500 bp
of the Xenopus laevis Pomc gene promoter directs GFP
expression to cells of the intermediate lobe, but not the hypo-
thalamus, of transgenic frog embryos [58], suggesting that the
function of the proximal Pomc promoter in driving pituitary
expression is ancestral in vertebrates.
In the mouse hypothalamus, Pomc expression depends on
a distal module that we identified in the pre-genomic era fol-
lowing a tedious chromosome walking and deletional
analysis in transgenic mice [59]. Upon release of the first
human genome draft, we were able to perform a human–
mouse phylogenetic footprinting that revealed the presence
of two highly conserved sequences, later also found in
other mammalian genomes, which proved to drive reporter
gene expression to POMC hypothalamic neurons [60].
These neuronal Pomc Enhancers, that we named nPE1 and
nPE2, are located at 212 and 210 kb relative to the mouse
transcription start site (TSS) [60]. While nPE2 is found in
monotremes (egg-laying mammals) and marsupials, as well
as placental mammals, nPE1 is only found in placentals
[46,47]. No sequences similar to either nPE enhancer can be
identified in non-mammalian genomes. A detailed phyloge-
netic analysis of both enhancers revealed that nPE1 and
nPE2 are derived from unrelated ancient transposable
elements (TEs) that were independently co-opted—or
exapted—at different times during early mammalian evol-
ution [46,47,61]. nPE2 was derived from a CORE-SINE
retroposon before the mammalian radiation [46], whereas
nPE1 is derived from an MaLR retroposon inserted at the
time of the placental mammal diversification [47]. Transgenic
mouse studies showed that either nPE1 or nPE2 is able to
drive authentic reporter gene expression to POMC hypo-
thalamic neurons, whereas the simultaneous absence of
both enhancers from a 4 kb mouse neuronal distal module
completely inactivates this function [60]. More recently, we
reported a first case of convergent evolution of cell-specific
transcriptional enhancers by demonstrating that nPE1 and
nPE2 control a fully overlapping spatio-temporal expression
domain in the ventral hypothalamus [47,61].
While nPE1 and nPE2 explain neuronal Pomc expression in
mammals, nothing is known about the regulatory regions con-
trolling hypothalamic Pomc expression in all other vertebrate
classes. Because nPE1 and nPE2 are derived from TEs exapted
in the mammalian lineage, they should be non-orthologous to
Pomc regulatory regions in other vertebrates (figure 1). With
this in mind, here we attempt to investigate the following
aspects of Pomc regulatory evolution: (i) can the mammalian
enhancers be recognized by the trans-acting machinery
of the teleost hypothalamic neurons? (ii) What is/are the
enhancer/s controlling Pomc expression in the zebrafish hypo-
thalamus? (iii) Are the zebrafish neuronal Pomc enhancer/s
conserved in genomes from other teleost suborders?2. Material and methods
(a) Transgenic zebrafish
Adult stocks of strain AB wild-type zebrafish (D. rerio) obtained
from the Zebrafish International Resource Center (University of
Oregon, USA) were maintained at 28.58C on a 14 L : 10 D cycle.All embryos were collected by natural spawning and were
raised at 288C in E3 medium (5 mM NaCl, 0.17 mM KCl,
0.33 mM CaCl2, 0.3 mM MgSO4 and 0.1% methylene blue) in
Petri dishes. Transposase mRNA was synthesized in vitro using
mMESSAGE mMACHINE Sp6 kit (Ambion, Inc.) from pCS-TP.
One nanolitre of a DNA/RNA solution containing 25 ng ml21
of circular DNA (transgene vectors) and 35 ng ml21 of transpo-
sase mRNA were co-injected into one cell fertilized egg.
Quantification and selection of positive transgenic zebrafish
was carried out in tricaine-anaesthetized embryos and viewed
in an Olympus BX41 fluorescent microscope coupled to an
Olympus DP71 digital camera. Patterns of neuronal enhancer
activity were confirmed by transient injections (300–1000
embryos injected for each construct in at least three different
days). Five-day-old transgenic embryos were screened for
enhanced green fluorescent protein (EGFP) expression in the
pituitary (used as a positive control for the transgene activity)
and in the hypothalamus. Around 80–90% of injected embryos
express EGFP in the pituitary. Only those embryos expressing
EGFP in both the pituitary and hypothalamus were considered
to be positive for neuronal enhancer activity. All procedures
were performed in accordance with the Guide for the Care and
Use of Laboratory Animals, United States Public Health Services.(b) DNA constructs
The plasmid pT2KXIG containing Tol2 sequences for transposase
recognition (gift from Koichi Kawakami) was modified to replace
the pEF1a promoter and the intron of rabbit b-globin (cut by
XhoI and BamHI) with a 991 bp (2562/þ428) fragment, includ-
ing the zebrafish pomca promoter, the entire first exon and
intron, and 22 bp of the second exon, to yield transgene 1
(Tg1). An approximately 4 kb DNA fragment containing mouse
neuronal enhancer elements nPE1 and nPE2 located at 213
and 29 from mouse Pomc was subcloned into Tg1 upstream of
the zebrafish promoter using XhoI and an introduced XmaI site
to yield Tg2. Additionally, the following constructs with differ-
ent deletions (D) of Pomc neuronal enhancers were subcloned
into Tg1 using XhoI, and then characterized for correct orien-
tation: DnPE1 (Tg3), DnPE2 (Tg4) and DnPE1–DnPE2 (Tg5),
all in the 213/29 mouse Pomc context (see details in de Souza
et al. [60]). All fragments were first PCR amplified with
Pfx DNA polymerase (Invitrogen), subcloned into pZErO-2
(Invitrogen) and sequenced before subcloning into Tg1 vector.
Several zebrafish fragments located upstream of pomca were
amplified using a bacterial artificial chromosome (BAC) clone
(RP71–36D5) as template. First, two consecutive fragments of
4.2 (210.6/26.4) and 5.8 kb (26.4/20.56) were amplified by
PCR (TaKaRa Ex Taq), linked together at a natural BamHI site
located at 26.4, and then subcloned into Tg1 in artificially
added XhoI and XmaI sites (Tg6). Additionally, three fragments
encompassed in the 210.6/20.56 zebrafish region included in
Tg6 were PCR amplified with Pfx DNA polymerase (Invitrogen),
subcloned into pZErO-2 and finally subcloned with XhoI
upstream of the pomca promoter in Tg1 to generate Tg7
(23/20.6), Tg8 (26.9/24) and Tg9 (210.6/26.9). Further dis-
section of the 3.6 kb Tg9 was performed by restriction
digestion using either MluI and EcoRV (eliminating a 1273 bp
fragment), followed by fill-in reaction and blunt ligation, to
analyse the 50 region of 2327 bp (Tg10, 210.6/28.2), or diges-
ted with ApaI and EcoRV (eliminating a 2327 bp fragment),
followed by fill-in reaction and blunt ligation to analyse the 30
1273 bp fragment (Tg11, 28.2/26.9). Three sites of Tg11
(indicated in figure 4d ) were mutated from TAAT to TGGT by
PCR using overlapping megaprimers bearing the mutations.
The resulting mutated 1273 bp fragment was subcloned
into pZErO-2, sequenced and then subcloned into Tg1 using
XhoI sites present in the primers to yield Tg12. All plasmid
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(c) Whole-mount mRNA in situ hybridization
Whole-mount in situ hybridization was performed essentially as
described by Thisse et al. [62] with the following modifications:
larvae were grown in a buffer containing 0.2 mM 1-phenyl-
2-thiourea from 24 h post-fertilization onwards to remove
pigmentation. After fixation in 4% paraformaldehyde, 5 days-post
fertilization (dpf) larvae were permeabilized in proteinase K
(10 mg ml21) for 30 min. Riboprobe was synthesized with DIG
RNA labelling kit (Roche) according to manufacturer’s instructions
using a zebrafish pomca template plasmid which included a 623 bp
sequence from exon 3 cloned into pGEM-Teasy (Promega). The tem-
plate plasmid was digested with ApaI and transcribed with Sp6 to
generate digoxigenin-labelled antisense riboprobe. Pre-hybridiz-
ation and hybridization were performed at 658C. After stringent
washing, incubation in blocking solution (1 PBS/Tween, 2%
sheep serum, 2 mg ml21 bovine serum albumin) was performed
for 1 h at room temperature followed by incubation with alkaline
phosphatase-coupled anti-digoxigenin antibody (Roche) by shaking
at 1 : 2000 for 2 h at room temperature. The reaction was developed
with NBT/BCIP (Roche) in the dark. Larvae were cleared in 70%
glycerol and mounted for photography on an Olympus BX41
fluorescentmicroscope coupled to anOlympusDP71digital camera.
(d) Immunohistochemistry on cryosections
Five dpf larvae or adult zebrafish brains were fixed for 2 h in 4%
paraformaldehyde in PBS at 48C. They were rinsed three times in
PBS, cryoprotected in 10% sucrose in PBS, immersed in 10% gela-
tin/10% sucrose/PBS, fast frozen in isopentane and stored at
2808C until use. Cryosections (16 mm) were incubated overnight
at 48C with rabbit polyclonal anti-human ACTH–IC-1 (1 : 700;
National Hormone and Pituitary Program, National Institutes of
Health) and mouse monoclonal anti-EGFP (1 : 700; MAB3580,
Millipore) in KPBS (0.9% NaCl, 16 mM K2HPO4, 3.6 mM
KH2PO4)/0.3% Triton X-100, 2% normal goat serum. Following
several washes with KPBS, primary antibodies were detected
using Alexa-555 anti-rabbit immunoglobulins and Alexa-488
anti-mouse immunoglobulins conjugated secondary antibodies
(Invitrogen), diluted 1 : 1000 in KPBS/0.3% Triton X-100. Images
were taken either with an Olympus BX41 fluorescent microscope
or, for confocal images, with a Nikon Eclipse E800.
(e) Bioinformatic analysis
Comparative analysis of mouse nPE2 and zebrafish 1.2 zfnPE
sequences to detect TFBSs was performed using the matrix-
based program MATINSPECTOR (www.genomatix.de), which uses
a large and updated library of TFBS weight matrices [63]. Mul-
tiple sequences were compared using the PIPMAKER program
(http://bio.cse.psu.edu/pipmaker).3. Results: functional conservation of neuronal
Pomc enhancers in mammals and zebrafish
(a) Mammalian neuronal enhancers drive reporter gene
expression to zebrafish POMC hypothalamic neurons
The mammalian Pomc gene is expressed in the pituitary and
the arcuate nucleus of the ventral hypothalamus [60]. In the
zebrafish and other teleosts, apart from the pituitary, the
pomca gene is expressed in the nucleus lateralis tuberis (NLT)
[51,64], considered a homologous structure to the mammalian
arcuate nucleus [65]. Hence, expression of Pomc in the ventralhypothalamus is a primitive feature of the common ancestor of
ray-finned fishes and tetrapods. However, enhancers nPE1 and
nPE2,which control hypothalamicPomc expression in themam-
malian brain, are mammalian novelties, as they resulted from
the exaptation of TEs at the base of the mammalian radiation
[61]. Consistent with this, we used the PIPMAKER program [66]
to perform multiple local alignments between the mouse and
human Pomc loci and the region encompassing approximately
40 kb around the pomca locus in zebrafish chromosome 17
(contig AL590149.9, Zv9), but no non-coding regions could be
aligned between these species (data not shown).
To check whether the mammalian enhancers, in spite of
their relatively recent evolutionary origin, could be recognized
by the transcriptional machinery of zebrafish hypothalamic
POMC neurons, we created transgenic zebrafish carrying the
mouse distal neuronal Pomc enhancer module using Tol2-
transposon-based constructs. A transgene series was built
using an approximately 1 kb region of the zebrafish pomca
gene that encompasses 451 bp of the upstream promoter,
exon 1 (85 bp), intron 1 and 22 bp of exon 2 that were fused
to EGFP coding sequences (figure 2b). This region has been
shown by Liu et al. [52] to drive robust EGFP expression to
the distal and intermediate lobes of transgenic zebrafish, but
not to the hypothalamus, a result that we reproduced here
(figure 2b, Tg1). Next, we inserted the mouse distal neuronal
Pomc enhancer module corresponding to 213 and 29 kb
from the mouse Pomc TSS upstream of the zebrafish promoter
construct (figure 2b, Tg2). Interestingly, constructs carrying
this module drove EGFP expression to the zebrafish embryo-
nic hypothalamus at 5 dpf (figure 2b, Tg2). In whole-mount
embryos, positive hypothalamic neurons are seen as a small
group of cells located anteriorly to the pituitary. This latter
tissue also expresses EGFP, because the construct carries the
zebrafish proximal promoter (figure 2b, Tg2). In total, of 717
embryos displaying EGFP expression in the pituitary, 179
(25%) also showed EGFP cells in the ventromedial hypo-
thalamic area, with very little, if any, ectopic expression in
the brain, retina or other body areas. To confirm the identity
of EGFP-expressing neurons, we checked for co-expression
of EGFP and POMC by immunofluorescence in sections of
5 dpf-transgenic embryos using an antibody against the
human adrenocorticotropic hormone (ACTH) peptide,
which is very similar to POMCa-derived zebrafish ACTH
[51,67] and efficiently labels zebrafish POMC neurons.
Approximately 30 ACTH-positive neurons arranged as two
arcs around the midline are detected per embryo and, of
these, approximately 50% are also EGFP-positive. We have
also detected transgenic expression in a few neurons located
within the array of ACTH-immunoreactive (ir) neurons but
that were not labelled with the ACTH antibody. It remains
to be determined whether these neurons show ectopic trans-
genic expression or the human ACTH antibody fails to label
the entire population of zebrafish POMCa-expressing neurons.
To check whether the 4-kb mouse regulatory region is also
functional in the adult fish brain, we grew and mated Tg2 F0
transgenic zebrafish and created F1 transgenic lines. From
one of these lines, we collected many 5 dpf F2 embryos and
observed that all of them expressed EGFP in the pituitary
and in approximately 50% of ACTH-ir neurons of the hypo-
thalamus (figure 3a). EGFP-positive neurons were also
observed in the NLT of the ventral hypothalamus of three-
month-old F2 transgenic adults inwhich, again, approximately
50%of humanACTH-ir neurons coexpressed EGFP (figure 3b).
(b)
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Figure 2. Mouse neuronal Pomc enhancers drive EGFP expression to POMC hypothalamic neurons in transgenic zebrafish. (a) (i) Zebrafish pomca gene. Black boxes
represent exons. (ii) Drawing of a 5 dpf zebrafish head in a horizontal plane showing the distribution of pomca-expressing cells in the pituitary and hypothalamus
(red dots). The blue rectangle depicts the representative area shown in the other panels. (iii) ACTH-ir cells on a horizontal section of a 5 dpf zebrafish brain. Hyp, NLT
of the hypothalamus; AP and PP, anterior and posterior pituitary lobes, respectively. (iv) Horizontal view of a whole-mount in situ hybridization for pomca.
(b) Expression analysis of transgenes driving EGFP under the control of zebrafish proximal pomca sequences (20.6 to þ0.4 kb; in black) and a neuronal
mouse Pomc distal module (grey line) carrying enhancers nPE1 (blue box) and nPE2 (red box) in transgenic zebrafish. Pictures show horizontal cryosections of
5 dpf zebrafish brains subjected to double immunohistochemistry against ACTH (left column, in red) and EGFP (central column, green). Right superimposed
images show coexpression of POMC and EGFP (white arrows). Asterisk: non-specific signal. Transgenes are described in scale on the left, numbered in the
centre (TgX) and expression analysis shown on the right.
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ory region drives EGFP expression with similar efficiency in
embryos and adult zebrafish POMC neurons.
The results above show that a distal neuronal regulatory
region of mouse Pomc can be recognized by the zebrafish
transcriptional machinery despite the fact that these two ver-
tebrate lineages split 450 Ma. This 4 kb distal module carries
the enhancer analogues nPE1 and nPE2, and previous studies
showed that either nPE1 or nPE2 is able to drive reporter
gene expression to POMC hypothalamic neurons in trans-
genic mice [60]. Thus, we asked whether expression in
transgenic zebrafish depended on one or both mammalianenhancers. To this end, we tested deletion constructs in
which nPE1 (DnPE1), nPE2 (DnPE2) or both enhancers simul-
taneously (DnPE1/DnPE2) were removed (figure 2b; Tg3–5).
As previously found in transgenic mice [60], DnPE1 and
DnPE2 constructs still drove EGFP expression to the zebrafish
hypothalamus (figure 2b, Tg3 and Tg4), with 51/250 and
55/260 5 dpf embryos showing hypothalamic EGFP
expression relative to transgenic signal in the pituitary,
respectively. Immunofluorescence experiments showed simi-
lar levels of ACTH/EGFP colocalization for Tg3 and Tg4 to
that of Tg2 (figure 2b). By contrast, simultaneous deletion
of both enhancers led to a complete loss of EGFP expression
ACTH EGFP merge
ACTH EGFP merge
OB
Tel
NLT
MO
Cb
OpT
(b)
(a) (i)
(i)
(ii) (iii) (iv)
(ii) (iii)
Figure 3. Functional conservation of the mouse neuronal Pomc enhancer module in a transgenic zebrafish line. (a) Horizontal sections of F2 zebrafish (5 dpf )
carrying Tg2 (figure 2). Pictures show horizontal cryosections of a zebrafish brain subjected to double immunohistochemistry against (i) ACTH, (ii) EGFP and
(iii) superimposed images. (b) (i) A diagram of a sagittal section of an adult brain in which the area shown in (ii– iv) is indicated by a square. OB, olfactory
bulb; NLT, nucleus lateralis tuberis of the hypothalamus; Tel, telencephalon; OpT, optic tectum; Cb, cerebellum; MO, medulla oblongata. (ii– iv) Magnifications
of a sagittal cryosection of the NLT area of an adult zebrafish of the transgenic line Tg2 subjected to double immunohistochemistry against (ii) ACTH,
(iii) EGFP and (iv) superimposed images. White arrows indicate representative neurons with colocalization of the ACTH and EGFP signals.
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clude that the ability of the 4 kb mouse regulatory region
to drive reporter gene expression to the zebrafish hypothala-
mus depends on the presence of either nPE1 or nPE2, which
seem here to play overlapping regulatory roles, as observed
previously in transgenic mice [47,60].
(b) Identification and characterization of a neuronal
regulatory region of zebrafish pomca
Comparative studies of Pomc transcriptional regulation
between mammals and fishes would greatly profit from the
characterization of the zebrafish cis-elements that control
hypothalamic pomca expression. Bioinformatic analyses
failed to detect sequences similar to nPE1 or nPE2 in the zeb-
rafish genome. Likewise, phylogenetic footprinting studies
performed between the pomca zebrafish locus and sequences
available from other teleost fish genomes failed to detect con-
served non-coding regions. Therefore, in order to search for a
putative zebrafish neuronal Pomc enhancer (zfnPE), we
returned to a classical deletional analysis in transgenic zebra-
fish, similar to that we did 15 years ago to detect the mouse
distal neuronal module [59] but, in this case, aided by anassembled zebrafish BAC genomic library. Using a combi-
nation of DNA primers and the BAC clone RP71–36D5, we
assembled a transgene similar to Tg1 but with approximately
11 kb of 50 flanking sequences of zebrafish DNA (figure 4b,
Tg6). Tg6 led to the expression of EGFP in the ventromedial
hypothalamus in 67 (17%) out of 394 transgenic embryos
(5 dpf) showing EGFP-positive expression in the pituitary,
and immunofluorescence analyses showed that hypothalamic
EGFP was expressed in POMC neurons (figure 4c), indicating
that a zebrafish neuronal regulatory module resides within
the 11 kb genomic region. To narrow down this element
further, we created a series of three deletions of the 11 kb
upstream region (figure 4b; Tg7–Tg9) and observed that
only the most distal, 3.6 kb segment, located between 210.6
and 26.9 kb of pomca exon 1, could drive EGFP expression
to the hypothalamus (figure 4c; Tg9), with a hypothala-
mus/pituitary proportion of 57/398 (14%). By contrast,
constructs Tg7 and Tg8, covering the region between 26.9
to 20.6 kb from pomca exon 1, were expressed only in the
pituitary. We further divided the 3.6 kb region into a 5’
(210.6 to 28.2 kb; Tg10) and a 3’ portion (28.2 to 26.9 kb;
Tg11) and produced transgenic zebrafish. While the 3’ part
was as efficient as the original Tg6, showing a 77/391
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Figure 4. Identification and characterization of a zebrafish pomca neuronal enhancer. (a) Genomic structure of the zebrafish pomca locus. The 50 flanking angio-
poietin-like (angpl) and 30 efr3ba genes are indicated. Exons are depicted in boxes. Pomca exons and angpl exon1 are numbered. (b) Set of transgenes (Tg) that
carry variable lengths of 50 flanking regions of zebrafish pomca fused to EGFP coding sequences used for the identification of a pomca neuronal zebrafish enhancer.
Arrows in Tg12 point to the location of nucleotide substitutions indicated with asterisks. Number and percentage of positive EGFP embryos in the hypothalamus
relative to embryos expressing EGFP in the pituitary (Hyp/Pit) are indicated on the right. (c) Horizontal brain cryosections of transgenic zebrafish (5 dpf ) subjected to
double immunohistochemistry against ACTH (left), EGFP (centre) or superimposed images that show coexpression (right, white arrows). Hyp, NLT of the hypothala-
mus; AP, anterior lobe of the pituitary. (d) Sequence of Tg11 mutated in Tg12. Homeobox conserved elements are shown in red (zebrafish sequence) or blue
(orthologous sequence in mammalian nPE2). Mutated A to G nucleotides are underlined including a nearby TAAT site. Coloured lines indicate putative
transcription factor families that could bind to the mutated sequences.
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expression very inefficiently with only a 5/233 hypothala-
mic/pituitary ratio (2%), suggesting that a zfnPE resides in
the 1.2 kb region present in Tg11 (figure 4c).
Because the zebrafish enhancer zfnPE and the mamma-
lian enhancers nPE1 and nPE2 drive EGFP expression to
the same array of hypothalamic POMC neurons in transgenic
zebrafish, it is tempting to speculate that they share common
DNAmotifs recognized by the unique set of transcription fac-
tors present in these neurons. To begin pinpointing these
regulatory elements, we made an exhaustive BLAST search
of the 1.2 kb zebrafish region (chr17 : 33 424 669–33 425 868;
Zv9/danRer7) to find DNA elements also present in mam-
malian enhancers nPE1 (586 bp) and nPE2 (180 bp). We
found 10 short motifs (between 16 and 18 bp) of more than
85% identity between mouse nPE2 and the 1.2 kb zebrafish
sequence containing zfnPE. We selected two of these motifs
because they are embedded within a 50 bp fragment that
was shown to be essential for nPE2 enhancer function in
transgenic mice [46]. These two motifs contain TAAT
sequences normally found in homeodomain TFBSs, that we
substituted for mutant variants carrying TGGT (figure 4c,
Tg12 and figure 4d ). Strikingly, transgenic zebrafish embryos
bearing Tg12 failed to express EGFP in the brain while retain-
ing the ability to express the reporter gene in the pituitary
(figure 4c), indicating that these two elements play a critical
role in pomca neuronal expression within the 1.2 kb region.
Because transcription factors controlling hypothalamic Pomc
expression remain unknown, we searched for common
TFBSs present in the mutated regions of zfnPE and in mam-
malian nPE2. We found 10 candidate transcription factor
families (figure 4d ) that could help identify transcription fac-
tors that drive neuronal-specific Pomc expression. A complete
list of common TFBSs shared by mammalian nPE1 and nPE2
as well as by zebrafish zfnPE and a tetraodon upstream
element (see below) is shown in the electronic supplementary
material, figure S1.
The mutated TAAT sites present in zfnPE are included in a
region annotated in the UCSC Genome Browser (www.
genome.ucsc.edu) as a hAT Charlie DNA transposon (DNA-
8–14_DR), a family of DNA transposons that is highly abun-
dant in the D. rerio genome [68]. One peculiarity found in
the recently published zebrafish genome is the unusually
large proportion of sequences derived fromDNA transposons
relative to those originated from retrotransposons, in clear con-
trast towhat has been found inmost other vertebrate genomes,
including the other four available Acanthopterygii fishes [68].
In this regard, our finding that the pomca locus of medaka,
stickleback, tetraodon and fugu is devoid of sequences derived
from a hAT Charlie strongly suggests that insertion of this
DNA transposon upstream of zebrafish pomca is a relatively
recent event. Future genome projects will help us to determine
whether exaptation of zfnPE from a hAT Charlie DNA trans-
poson occurred solely in zebrafish, in Cypriniformes or in
the lineage leading to Ostariophysi.
In addition, the 1.2 kb zebrafish enhancer module maps
within a predicted transcriptional unit of a gene that encodes
for a protein similar to angiopoietin-like (angpl). This gene
has a conserved position in relation to Pomc that dates back
to the bony fish ancestor of teleosts and tetrapods, although
it is not found in placental mammals [51]. The 1.2 kb
module particularly contains the putative first exon and
part of the first intron of the gene, and further studies willbe necessary to establish whether zfnPE includes an active
or extinct coding exon as has been reported for other ver-
tebrate enhancers [69,70]. Although a paralogue of putative
angpl1 exon 1 is also found upstream of pomcb, the fragment
carrying the two mutated TAAT sites of zfnPE seems to be
absent from the angpl1/pomcb locus. Moreover, we failed to
detect hAT Charlie derived-sequences in the pomcb locus,
suggesting that insertion of this DNA transposon upstream
of pomca occurred after the whole-genome duplication that
took place in teleosts around 320 Ma [51].
(c) Identification and characterization of a neuronal
regulatory region of tetraodon pomca
Similar to placental mammals, some members of the teleost
superorder Acantomorpha—including tetraodon, fugu and
medaka—also lack the angpl locus in the 50 region of pomca,
suggesting that these fishes might use a neuronal enhancer
different from zfnPE to express pomca in the ventromedial
hypothalamus. In fact, comparisons of the zebrafish pomca
locus with those of other vertebrates did not yield any con-
served non-coding element. However, when the 50 flanking
region of pomca from fugu was used in a phylogenetic foot-
printing analysis together with orthologous genomic
sequences taken from other teleosts, we detected an 80 bp
region that is conserved in representative species of the super-
order Acanthomorpha, including tetraodon (T. nigroviridis),
three-spined stickleback (Gasterosteus aculeatus) and medaka
(Oryzias latipes) but not in zebrafish pomca or pomcb, a teleost
that belongs to the superorder Ostariophysi (figure 5a). To
check whether this conserved element might be an enhancer,
we cloned a 426 bp fragment of the tetraodon pomca locus
upstream of the zebrafish pomca promoter (figure 5b; Tg13),
and the construct was tested in transgenic zebrafish. We
observed that Tg13 is expressed in the ventromedial
hypothalamus of zebrafish (25 embryos positive in the hypo-
thalamus among 202 positive in the pituitary), and that a few
cells colocalize with ACTH (figure 5c). This result indicates
that the 426 bp sequence located in the 50 flanking region of tet-
raodon pomca harbours a hypothalamic pomca enhancer. The
presence of an 80 bp conserved element in the four Acantho-
morpha species used in this study suggests that this enhancer
could be active in all members of this superorder. In the
same hypothalamic area where we observed coexpression of
EGFP and POMC, we have also observed other EGFP-positive
neurons that were not colabelled with the anti-human ACTH
antibody. These hypothalamic neurons may represent another
neuronal population to be identified.4. Discussion
(a) Conservation of function by non-homologous
enhancers in vertebrate evolution
Here, we show that mouse Pomc enhancers nPE1 and nPE2
can drive expression to POMC neurons of the zebrafish hypo-
thalamus, even though DNA sequences similar to these
elements cannot be found in the genomes of any non-
mammalian vertebrate. Indeed, nPE2 is present in all mam-
malian groups, whereas nPE1 can be found only in
placental mammals ([46,47] and figure 6). Evidence that
nPE enhancers are mammalian novelties comes from detailed
100%
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zebrafish - a
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tetraodon pomca
tetraodon
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Figure 5. Identification of a conserved sequence in Acanthomorph fishes which drives EGFP expression to hypothalamic POMC neurons. (a) (i) Phylogenetic foot-
printing PipMaker analysis of fugu pomca and 50 flanking sequences in comparison with homologous DNA taken from tetraodon, stickleback, medaka and zebrafish
pomc a and b. A conserved block is shown in pink. (ii) Location of the conserved sequence is indicated with a pink box in the pomca 50 flanking regions of each
species relative to exon 1 (black box). (b) (i) Scheme of tetraodon pomca gene. Exons are numbered. Pink area corresponds to the segment included in Tg13 shown
on the right that maintains the basic structure of previous transgenes. (c) Horizontal brain cryosections of zebrafish (5 dpf ) carrying Tg13 subjected to double
immunohistochemistry against (i) ACTH, (ii) EGFP or (iii) superimposed images. Coexpression is indicated by white arrows. Hyp, NLT of the hypothalamus; AP,
anterior lobe of the pituitary.
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from TE sequences: nPE2 is most similar to TEs of the
CORE-SINE subfamily [46], which are very abundant in
mammalian genomes [71,72], whereas nPE1 is most similar
to a long terminal-repeat retrotransposon of the MaLR sub-
family [47], which is also restricted to mammals [73]. The
limited phylogenetic distribution of nPEs, and the fact that
they are more similar to TEs of mammals, strongly indicates
that these enhancers are mammalian novelties (figure 6). As a
consequence, nPEs are predicted to be analogous, but not
homologous (orthologous), to the neuronal Pomc regulatory
regions of other vertebrate groups.
Other works have indicated that mammalian enhancers
can drive expression to zebrafish embryos in the absence of
overt sequence conservation [39,43,74,75], but in these studies
it was not clear whether the mammalian enhancers had origi-
nated de novo in the mammalian lineage or if they were
divergent orthologues to those of zebrafish. As indicated by
the work of Taher et al. [45], which used NCEs of theamphibian Xenopus as an intermediate species to find
divergent mammalian and zebrafish NCEs, orthologous ver-
tebrate enhancers can become so dissimilar by extensive
mutations in TFBSs and intervening sequences that computer
algorithms may fail to identify them. Thus, the defined
timing of origin of nPEs makes them, to the best of our
knowledge, the first bona fide non-homologous vertebrate
enhancers that show conserved function in mammals and tel-
eosts. Conclusive de novo generation of vertebrate enhancers
has also been shown in the teleost fish medaka, in which
three enhancers that are only active in medaka are derived
from degenerating exonic sequences, but in these cases the
enhancers were shown to be active only in medaka itself [70].
Even mammalian enhancers that have zebrafish homol-
ogues can fail to drive specific, eutopic expression in
transgenic fish. In a comparative enhancer study, Ritter et al.
[40] observed that of 13 orthologous human and zebrafish
enhancers tested, only four (31%) yielded similar expression
patterns in transgenic zebrafish embryos. A larger study
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Figure 6. Phylogenetic tree showing the hypothetical turnover of neuronal Pomc enhancers (nPE) along vertebrate evolution. Mammalian nPE1 (red) and nPE2
(blue), zebrafish zfnPE (orange) and a putative enhancer of Acanthopterygii (green) seem to be evolutionary unrelated functional analogues. The coloured circles
indicate the probable time of origin as functional enhancers. The black circle indicates the origin of a putative ancestral nPE and the question marks depict the
current lack of identity for nPEs in various vertebrate classes or lineages that express Pomc in the ventromedial hypothalamus.
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found that 36% displayed radically different expression pat-
terns in mouse and zebrafish transgenesis. Given this
context, it is particularly striking that nPEs, which are not
homologous to enhancers in zebrafish, nevertheless gave
specific expression in zebrafish hypothalamic POMC neurons.
NCEs conserved between mammals and teleosts are
typically located close to genes encoding transcription fac-
tors and receptors involved in embryonic development,
probably because these genes require tight temporal and
spatial regulation [19,20]. Although it is expressed early
during organogenesis, hypothalamic POMC has no known
developmental function. Instead, it is necessary for fitness
in adulthood, but even then, hypothalamic Pomc mRNA
levels can vary widely without gross physiological effects
[76]. Thus, non-developmental genes such as Pomc may be
particularly prone to enhancer turnover.
The fact that the mammalian enhancers direct reporter
gene expression to zebrafish POMC neurons indicates that
the specific set of transcription factors that defines a Pomc-
expressing hypothalamic neuron is present in both mamma-
lian and teleost POMC neurons. Thus, the cis-acting motifs
controlling Pomc neuronal expression in the zebrafish
should be very similar to those present in the mouse enhan-
cers, meaning that the cis/trans code of neuronal Pomc
expression has been conserved since the times of the bony
fish ancestor. The fact that nPEs are mammalian novelties
indicates that their cis-elements had to be created de novo
before the new enhancers eventually replaced the ancestral
Pomc regulatory elements during early mammalian evolution
(figure 1). We observed, however, that nPEs reproducibly
drove EGFP expression to only around 50% of zebrafish
POMC neurons, and there was EGFP expression in some
non-POMC-ir neurons within the zebrafish hypothalamus.
This apparent lack of perfect targeting precision, foundeven in transgenic studies with CNEs [40,44], is probably
due to species-specific differences in Pomc regulation and is
hardly surprising considering the evolutionary distance
between mammals and teleosts.
The mammalian arcuate nucleus and the teleost NLT are
generally considered to be homologous anatomical structures
since they are both located in the ventromedial hypothalamus
and express a highly similar gene set, such as agouti-related
peptide (agrp) [64,77,78], somatostatin (sst) [79], growth hor-
mone releasing hormone (ghrh) [80], the leptin receptor
(lepr) [81] and Pomc [51,64]. The NLT and the arcuate also
show conserved function. In mammals, POMC-derived mel-
anocortin peptides produced by arcuate neurons play a
crucial role in the control of energy balance, and are antago-
nized by Agouti-related protein (AgRP), a peptide produced
by a separate population of arcuate neurons [50]. In fish, there
is abundant evidence that POMC melanocortin peptides and
AgRP also control energy balance [77,78,82–85]. Not every-
thing is conserved, though: while the mouse POMC
neurons coexpress the neuropeptide CART, and AgRP is
coexpressed with NPY, in zebrafish neither CART nor NPY
is expressed in the NLT [86,87].
Currently, little is known about transcription factors reg-
ulating neuronal Pomc expression in any animal model. Our
results suggest that the transcription factor repertoires of
POMC neurons in the arcuate nucleus and the NLT are simi-
lar and define, at least to some extent, a unique regulatory
code, consistent with the idea that the neurosecretory hypo-
thalamus is an ancient metazoan structure [88]. As nPEs are
functional both during zebrafish embryonic development
and adulthood, those common transcription factors are pre-
sent throughout the life of zebrafish POMC neurons. Given
the relative ease and low cost of genetic manipulation of zeb-
rafish compared with mice, our neuronal Pomc–EGFP
transgenic zebrafish line could provide a new tool to search
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expression, similar to the use of a zebrafish pituitary Pomc–
EGFP line to screen for mutations altering pituitary develop-
ment [89]. Genes affecting nPE1 and nPE2 function in
transgenic zebrafish are likely to be the same as those that
control the enhancers in mammals.
(b) Zebrafish pomca neuronal regulatory region
Pomc is not found in basal chordates but exists in all vertebrate
groups, including jawless fish (agnathans) and cartilaginous
fish [90]. In the agnathan lamprey, Pomc paralogues Poc and
Pom are expressed in the pituitary, but not in the brain [91],
whereas cartilaginous fish do express Pomc in the hypothala-
mus [92]. Thus, it seems that Pomc was originally a pituitary
gene that became transcriptionally active in the hypothalamus
in an ancestor to jawed fish (figure 6). In teleosts, amphibians
and mammals, the Pomc proximal promoter is responsible for
expression in the pituitary [52,54,56,58], but mammalian nPEs
are the only known neuronal regulatory regions of the gene.
The identification of Pomc neuronal cis-elements in other
vertebrates might help understanding the various paths that
enhancers can take during evolution. In a first step in this
direction, we sought to identify the regulatory elements that
control zebrafish Pomc in the hypothalamus. Comparative
genomics was of no use in this case, because non-coding con-
served regions could not be found around the zebrafish pomca
gene, even when comparing it with the pomca loci of other tel-
eosts. The reason for this is likely to be the distant
evolutionary relationship between the superorder Ostario-
physi, to which zebrafish belongs, and the superorder
Acanthomorpha, to which other sequenced teleosts such as
fugu, tetraodon, medaka and three-spined stickleback
belong [93]. The efficient use of fish comparative genomics
to find regulatory regions in zebrafish would greatly benefit
from the sequencing of the genomes of closer relatives such
as the channel catfish (Ictalurus punctatus), the common
carp (Cyprinus carpio) or the goldfish (Carassius auratus).
From an initial 10 kb region upstream of the pomca promo-
ter, we narrowed the pomca neuronal regulatory region down
to 1.2 kb. This distal fragment drove efficient EGFP expression
to ACTH-ir neurons of the zebrafish NLT. Thus, we consider
that this region harbours a bona fide neuronal Pomc enhancerthat we named zfnPE. Interestingly, the 1.2 kb region is
embedded within the locus immediately 5’ of pomca, encom-
passing exon 1 and part of intron 1 of a gene similar to
angpl. We have not yet determined whether the neuronal regu-
latory region is located within the intron or the exon, but
mutagenesis of three TAAT sites within the intron abolished
EGFP expression in the hypothalamus. These critical sites are
embedded within DNA sequences derived from a hAT Charlie
DNA transposon, a family of TEs present in high copy number
in the zebrafish genome. Further work is necessary to deter-
mine the birth date and phylogeny of this exaptation event
(figure 6). Establishing the precise cis-elements controlling zeb-
rafish pomca expression might help pinpoint the elements
regulating mammalian Pomc, because zfnPE, nPE1 and nPE2
are functional analogues.5. Concluding remarks
The de novo origin of enhancers is presumably an important
feature in the evolution of gene regulation. The appearance of
Pomc nPE enhancers early in the mammalian lineage offers a
clear example of how new enhancers can arise and eventually
replace ancestral ones while conserving the underlying
cis- and trans-regulatory codes (figure 6). This was possibly
facilitated by the fact that Pomc is not a gene involved in
development, making its regulation easier to be ‘tinkered’
with by evolution. Zebrafish is an ideal model for such
studies, because its phylogenetic distance to mammals
coupled with the ease to perform transgenesis offers many
possibilities to discover what is ancestral and what is derived
in mammalian regulatory evolution. At the same time, the
search for the regulatory regions in other species, as we
did here with zebrafish and tetraodon pomca, will illuminate
the evolutionary paths that regulatory regions can take in
different lineages during evolution.
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